Exercise therapy and lower extremity revascularization both improve walking performance in symptomatic patients with peripheral artery disease, concluded researchers after a comprehensive review of several randomized controlled trials.
Optimal implantation depth was found to be achieved in <30% of transcatheter aortic valve replacement procedures.
A tip detection method using a newly developed intravascular ultrasound-based three-dimensional wiring was found to superior to conventional method for chronic total occlusion-percutaneous coronary intervention.
Members of 4 societies published a consensus system of care document containing operator and institutional recommendations and requirements for transcatheter mitral valve interventions.
Recall of a cardiac resynchronization therapy pacemaker, which occurred in November 2015, was delayed unnecessarily.
Age, reduced renal function, immunocompromised status, prior procedures, and procedure type were found to represent independent predictors of risk of developing a cardiac implantable electronic device infection.
Among patients with STEMI and multivessel disease, the benefit of complete revascularization over culprit-lesion only PCI was consistent irrespective of the investigator-determined timing of nonculprit lesion intervention.
Findings do not support the contention that patients undergoing cardiac catheterization should have their beta blockers or ACE inhibitors suspended.
Researchers demonstrated that left ventricular unloading with transcatheter aortic valve replacement is associated with acute improvements in right ventricular function and right ventricular-pulmonary artery coupling.
Subcutaneous implantable cardioverter-defibrillator is a feasible option not only in patients without structural but also in a selected patient collective with structural heart disease.
